 Aaron Issaian
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 8 | 2026 | 749 | 1.290 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 23 | 0.690 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 3 | 2022 | 348 | 0.560 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 459 | 0.470 |
Why?
| | Protein Domains | 5 | 2026 | 313 | 0.420 |
Why?
| | Fluid Therapy | 2 | 2026 | 156 | 0.420 |
Why?
| | Hemolysis | 3 | 2025 | 242 | 0.390 |
Why?
| | Resuscitation | 2 | 2026 | 318 | 0.370 |
Why?
| | Blood Preservation | 3 | 2025 | 346 | 0.310 |
Why?
| | Sepsis | 2 | 2026 | 671 | 0.290 |
Why?
| | Saccharomyces cerevisiae | 2 | 2026 | 584 | 0.280 |
Why?
| | Glucose | 3 | 2026 | 1051 | 0.270 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 70 | 0.270 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2026 | 20 | 0.240 |
Why?
| | Chondroitin Sulfates | 1 | 2026 | 35 | 0.230 |
Why?
| | RNA Splicing Factors | 1 | 2026 | 66 | 0.230 |
Why?
| | Glycocalyx | 1 | 2025 | 30 | 0.220 |
Why?
| | Receptor, Adenosine A2B | 1 | 2025 | 65 | 0.220 |
Why?
| | Caffeine | 1 | 2025 | 76 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.210 |
Why?
| | Vasoconstrictor Agents | 1 | 2025 | 150 | 0.210 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2026 | 415 | 0.210 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2024 | 34 | 0.210 |
Why?
| | Models, Molecular | 5 | 2021 | 1606 | 0.200 |
Why?
| | Glycolysis | 5 | 2026 | 341 | 0.200 |
Why?
| | Blood Donors | 2 | 2025 | 145 | 0.200 |
Why?
| | Pteridines | 1 | 2023 | 22 | 0.190 |
Why?
| | Furin | 1 | 2022 | 12 | 0.190 |
Why?
| | Oxidation-Reduction | 3 | 2021 | 1077 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2026 | 350 | 0.190 |
Why?
| | RNA Splicing | 2 | 2026 | 285 | 0.180 |
Why?
| | Aldehydes | 1 | 2023 | 140 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.180 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 55 | 0.170 |
Why?
| | Blood Banks | 1 | 2021 | 50 | 0.170 |
Why?
| | Altitude | 1 | 2026 | 470 | 0.170 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 69 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 129 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.150 |
Why?
| | Factor XIIIa | 1 | 2019 | 6 | 0.150 |
Why?
| | Prescription Drugs | 1 | 2021 | 111 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 451 | 0.150 |
Why?
| | Peptide Mapping | 1 | 2019 | 62 | 0.150 |
Why?
| | Solutions | 1 | 2019 | 160 | 0.140 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 959 | 0.140 |
Why?
| | Fibrin | 1 | 2019 | 84 | 0.140 |
Why?
| | Introns | 1 | 2019 | 260 | 0.140 |
Why?
| | Exons | 1 | 2019 | 365 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2021 | 936 | 0.130 |
Why?
| | Streptococcus pneumoniae | 1 | 2019 | 190 | 0.130 |
Why?
| | RNA | 1 | 2023 | 916 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 425 | 0.120 |
Why?
| | Blood Glucose | 1 | 2026 | 2359 | 0.110 |
Why?
| | Mice | 5 | 2026 | 18491 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
| | Metals | 1 | 2016 | 138 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2013 | 38 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1368 | 0.100 |
Why?
| | Indazoles | 1 | 2013 | 86 | 0.100 |
Why?
| | Peptides | 1 | 2019 | 1003 | 0.100 |
Why?
| | Animals | 7 | 2026 | 38410 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2019 | 976 | 0.090 |
Why?
| | Humans | 15 | 2026 | 147293 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 212 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1720 | 0.090 |
Why?
| | Signal Transduction | 1 | 2025 | 5272 | 0.090 |
Why?
| | Erythrocyte Transfusion | 2 | 2025 | 225 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4130 | 0.080 |
Why?
| | Metabolomics | 3 | 2021 | 736 | 0.070 |
Why?
| | Proteome | 2 | 2023 | 520 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2026 | 32 | 0.060 |
Why?
| | Proteins | 2 | 2022 | 1024 | 0.060 |
Why?
| | Glucose Transporter Type 1 | 1 | 2026 | 49 | 0.060 |
Why?
| | Syndecan-1 | 1 | 2025 | 44 | 0.060 |
Why?
| | Protein Binding | 2 | 2026 | 2249 | 0.050 |
Why?
| | Protein Conformation | 2 | 2021 | 943 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | Hyaluronic Acid | 1 | 2026 | 226 | 0.050 |
Why?
| | Male | 6 | 2026 | 73950 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2026 | 6041 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2026 | 784 | 0.040 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 30 | 0.040 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.040 |
Why?
| | NADP | 1 | 2021 | 52 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 51 | 0.040 |
Why?
| | Immune Evasion | 1 | 2021 | 63 | 0.040 |
Why?
| | Oxygen | 1 | 2026 | 998 | 0.040 |
Why?
| | Genome | 1 | 2022 | 306 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 219 | 0.040 |
Why?
| | Aged | 3 | 2026 | 26514 | 0.040 |
Why?
| | Protein Structure, Quaternary | 1 | 2019 | 116 | 0.040 |
Why?
| | Genome, Human | 1 | 2022 | 426 | 0.040 |
Why?
| | Spliceosomes | 1 | 2019 | 54 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1049 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 178 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 109 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2019 | 92 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 745 | 0.030 |
Why?
| | Hemoglobins | 1 | 2021 | 386 | 0.030 |
Why?
| | Cryoelectron Microscopy | 1 | 2019 | 223 | 0.030 |
Why?
| | Hypoxia | 1 | 2026 | 1208 | 0.030 |
Why?
| | Fibrinogen | 1 | 2019 | 180 | 0.030 |
Why?
| | Binding Sites | 1 | 2021 | 1319 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.030 |
Why?
| | Middle Aged | 3 | 2026 | 36821 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 675 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 502 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 391 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 593 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 305 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2016 | 152 | 0.030 |
Why?
| | Dimerization | 1 | 2016 | 189 | 0.030 |
Why?
| | Female | 4 | 2026 | 80076 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 332 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 166 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 728 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2134 | 0.030 |
Why?
| | Thrombosis | 1 | 2019 | 401 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 596 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3216 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4351 | 0.030 |
Why?
| | Manduca | 1 | 2013 | 2 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2013 | 15 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1171 | 0.030 |
Why?
| | Allosteric Regulation | 1 | 2013 | 100 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4604 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2021 | 3153 | 0.020 |
Why?
| | Carbon Monoxide | 1 | 2013 | 82 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 87 | 0.020 |
Why?
| | Models, Biological | 1 | 2021 | 1772 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 616 | 0.020 |
Why?
| | Heme | 1 | 2013 | 90 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2016 | 575 | 0.020 |
Why?
| | Protein Subunits | 1 | 2013 | 229 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 855 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 948 | 0.020 |
Why?
| | Adult | 2 | 2025 | 41405 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2013 | 892 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 14437 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22825 | 0.010 |
Why?
|
|
Issaian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|